In fact, in many types of cancer, including NB [43], MDM2 and MDMX are overexpressed or amplified, acting as oncogenes, and leading to therapeutic resistance and metastasis (reviewed in [44,45,46,47]). This evidence concerns the gene MDM2 and neuroblastoma.